Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT

NCT03596892 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Allogeneic Hematopoietic Stem Cell Transplantation
Conditions
Mixed-lineage-leukemia (MLL)-Rearranged Acute Leukemia

Interventions

DRUG: Decitabine
DRUG: Busulfan (BU)
DRUG: Cyclophosphamide (CY)

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]